Ignite Creation Date:
2024-05-05 @ 5:12 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00406848
Status:
COMPLETED
Last Update Posted:
2010-09-29
First Post:
2006-11-29
Brief Title:
A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly Patients
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Study Overview
Official Title:
Duloxetine Versus Placebo in the Long-Term Treatment of Patients With Late-Life Major Depression
Status:
COMPLETED
Status Verified Date:
2010-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to compare the efficacy and safety of duloxetine 60 mg once daily to placebo on depression in elderly patients greater than or equal to 65 years of age Patients who do not respond in the first 13 weeks will be eligible for rescue using pre-defined criteria Patients randomized to duloxetine 60 mgday meeting the rescue criteria will be increased to 120 mgday Patients randomized to the placebo arm meeting the rescue criteria will be assigned to duloxetine 60 mgday
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| F1J-US-HMFA | OTHER | Eli Lilly and Company | None |